HOOKIPA Pharma Inc. (HOOK) |
|
11.99 0.02 (0.17%)
|
02-21 16:00 |
|
Open: |
12 |
Pre. Close: |
11.97 |
|
High:
|
12.16 |
Low:
|
11.77 |
|
Volume:
|
38,758 |
Market Cap:
|
305M |
|
|
|
|
HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
12.166 - 12.226 |
12.226 - 12.287 |
|
Low:
|
11.63 - 11.692 |
11.692 - 11.754 |
|
Close:
|
11.89 - 11.989 |
11.989 - 12.088 |
|
Technical analysis |
as of: 2020-02-21 4:30:50 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 15.31  One year: 16.78 |
| Support: |
Support1: 11.07 Support2: 9.21 |
| Resistance: |
Resistance1: 13.11 Resistance2: 14.37 |
| Pivot: |
12.43  |
| Moving Average: |
MA(5): 12.06 MA(20): 12.47
MA(100): 9.77 MA(250): |
| MACD: |
MACD(12,26): 0.11 Signal(9): 0.27 |
| Stochastic oscillator: |
%K(14,3): 5.17 %D(3): 6.03 |
| RSI: |
RSI(14): 48.88 |
| 52-week: |
High: 14.38 Low: 6.06 Change(%): -14.4 |
| Average Vol(K): |
3-Month: 11914 10-Days: 5724 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.HOOK has closed above bottom band by 27.8%. Bollinger Bands are 26.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 23 Jan 2020 14:00:00 +0000
2 Small-Cap Biotech Stocks to Watch in 2020
Fri, 12 Jul 2019 18:03:35 +0000
Health Care Sector Update for 07/12/2019: HOOK,MDGS,ILMN
Fri, 12 Jul 2019 19:59:23 +0000
Health Care Sector Update for 07/12/2019: OHRP,HOOK,ILMN,NBSE
Fri, 12 Jul 2019 13:14:54 +0000
Health Care Sector Update for 07/12/2019: MDGS, HOOK, ILMN, JNJ, PFE, ABT, MRK, AMGN
Tue, 04 Jun 2019 21:13:01 +0000
5 Top Gainers In Pharma Sector (CVM, ALNA, SOLY...)
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqGS |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
21.59 |
| Shares Float (M) |
6.85 |
|
% Held by Insiders
|
14.94 |
|
% Held by Institutions
|
49.21 |
|
Shares Short (K)
|
298 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.960 |
|
Book Value (p.s.)
|
4.950 |
|
PEG Ratio
|
1.07 |
|
Profit Margin
|
-258.77 |
|
Operating Margin
|
-298.90 |
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
7.3 |
|
Gross Profit (p.s.)
|
-0.664 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.747 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-39.31 |
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
-4.05 |
|
P/E Growth Ratio
|
|
|
P/BV
|
2.42 |
|
P/S
|
10.51 |
|
P/CF
|
-6.59 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
